Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers Article

Kotsopoulos, J, Lubinski, J, Neuhausen, SL et al. (2006). Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers . GYNECOLOGIC ONCOLOGY, 100(1), 83-88. 10.1016/j.ygyno.2005.07.110

International Collaboration

cited authors

  • Kotsopoulos, J; Lubinski, J; Neuhausen, SL; Lynch, HT; Rosen, B; Ainsworth, P; Moller, P; Ghadirian, P; Isaacs, C; Karlan, B; Sun, P; Narod, SA

sustainable development goals

authors

publication date

  • January 1, 2006

published in

keywords

  • BRCA1
  • BRCA2
  • BREAST
  • CARCINOMA
  • ENDOMETRIAL
  • ESTROGEN PLUS PROGESTIN
  • Life Sciences & Biomedicine
  • OOPHORECTOMY
  • Obstetrics & Gynecology
  • Oncology
  • Science & Technology
  • TRIAL
  • WOMEN
  • case-control study
  • hormone replacement therapy
  • ovarian cancer

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 83

end page

  • 88

volume

  • 100

issue

  • 1